Halozyme Therapeutics reported $18.17M in Trade Creditors for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
DBV Technologies DBVT:US USD 15.37M 972K
Acadia Pharmaceuticals ACAD:US USD 10.01M 1.85M
Agios Pharmaceuticals AGIO:US USD 10.42M 2.62M
Alnylam Pharmaceuticals ALNY:US USD 40.57M 11.85M
Amarin AMRN:US USD 93.16M 23.15M
Aptinyx Inc APTX:US USD 474K 1.63M
Baxter International BAX:US USD 1.23B 48M
Cara Therapeutics CARA:US USD 15.22M 5.48M
Cytokinetics CYTK:US USD 14.43M 351K
Esperion Therapeutics ESPR:US USD 18.58M 5.75M
Halozyme Therapeutics HALO:US USD 18.17M 5.93M
Immunogen IMGN:US USD 20.18M 2.93M
Intercept Pharmaceuticals ICPT:US USD 21.3M 9.64M
Intra Cellular Therapies ITCI:US USD 14.22M 3.47M
Intrexon XON:US USD 4.2M 1.53M
IONIS PHARMACEUT IONS:US USD 20.54M 10.19M
JAZZ PHA JAZZ:US USD 102.25M 28.09M
Mannkind MNKD:US USD 9.87M 2.05M
Minerva Neurosciences NERV:US USD 533K 987K
Nektar Therapeutics NKTR:US USD 5.33M 7.02M
Peregrine Pharmaceuticals PPHM:US USD 23.33M 7.13M
Rigel Pharmaceuticals RIGL:US USD 2.72M 566K
Vanda Pharmaceuticals VNDA:US USD 5.58M 36K